Literature DB >> 33974565

What should define a SARS-CoV-2 "breakthrough" infection?

John S Schieffelin1, Elizabeth B Norton2, Jay K Kolls3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33974565      PMCID： PMC8203469          DOI： 10.1172/JCI151186

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   19.456


× No keyword cloud information.
  17 in total

1.  Influenza vaccine effectiveness in the community and the household.

Authors:  Suzanne E Ohmit; Joshua G Petrie; Ryan E Malosh; Benjamin J Cowling; Mark G Thompson; David K Shay; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-02-14       Impact factor: 9.079

Review 2.  Form and function for T cells in health and disease.

Authors:  Donna L Farber
Journal:  Nat Rev Immunol       Date:  2020-02       Impact factor: 53.106

Review 3.  Pneumococcal Vaccination Strategies. An Update and Perspective.

Authors:  Andrew C Berical; Drew Harris; Charles S Dela Cruz; Jennifer D Possick
Journal:  Ann Am Thorac Soc       Date:  2016-06

4.  Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.

Authors: 
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

5.  Vaccine Breakthrough Infections with SARS-CoV-2 Variants.

Authors:  Ezgi Hacisuleyman; Caryn Hale; Yuhki Saito; Nathalie E Blachere; Marissa Bergh; Erin G Conlon; Dennis J Schaefer-Babajew; Justin DaSilva; Frauke Muecksch; Christian Gaebler; Richard Lifton; Michel C Nussenzweig; Theodora Hatziioannou; Paul D Bieniasz; Robert B Darnell
Journal:  N Engl J Med       Date:  2021-04-21       Impact factor: 91.245

6.  The establishment of resident memory B cells in the lung requires local antigen encounter.

Authors:  S Rameeza Allie; John E Bradley; Uma Mudunuru; Michael D Schultz; Beth A Graf; Frances E Lund; Troy D Randall
Journal:  Nat Immunol       Date:  2018-12-03       Impact factor: 25.606

7.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Authors:  Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

8.  Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.

Authors:  William Daniel; Marc Nivet; John Warner; Daniel K Podolsky
Journal:  N Engl J Med       Date:  2021-03-23       Impact factor: 91.245

Review 9.  A Simple Approach to Pneumococcal Vaccination in Adults.

Authors:  Calvin Green; Christine Ann Moore; Akhilesh Mahajan; Kailash Bajaj
Journal:  J Glob Infect Dis       Date:  2018 Jul-Sep

10.  A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.

Authors:  Ahmed O Hassan; Natasha M Kafai; Igor P Dmitriev; Julie M Fox; Brittany K Smith; Ian B Harvey; Rita E Chen; Emma S Winkler; Alex W Wessel; James Brett Case; Elena Kashentseva; Broc T McCune; Adam L Bailey; Haiyan Zhao; Laura A VanBlargan; Ya-Nan Dai; Meisheng Ma; Lucas J Adams; Swathi Shrihari; Jonathan E Danis; Lisa E Gralinski; Yixuan J Hou; Alexandra Schäfer; Arthur S Kim; Shamus P Keeler; Daniela Weiskopf; Ralph S Baric; Michael J Holtzman; Daved H Fremont; David T Curiel; Michael S Diamond
Journal:  Cell       Date:  2020-08-19       Impact factor: 66.850
View more
  8 in total

1.  Simulation applications to support teaching and research in epidemiological dynamics.

Authors:  Wayne M Getz; Richard Salter; Ludovica Luisa Vissat
Journal:  BMC Med Educ       Date:  2022-08-20       Impact factor: 3.263

2.  A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.

Authors:  Mengxin Zhang; Ying Liang; Dongsheng Yu; Bang Du; Weyland Cheng; Lifeng Li; Zhidan Yu; Shuying Luo; Yaodong Zhang; Huanmin Wang; Xianwei Zhang; Wancun Zhang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

3.  In-depth Characterization of Vaccine Breakthrough Infections With SARS-CoV-2 Among Health Care Workers in a Dutch Academic Medical Center.

Authors:  Lidewij W Rümke; Femke C Groenveld; Yvonne M G van Os; Patrique Praest; Anniek A N Tanja; Dorien T C M de Jong; Jori Symons; Rob Schuurman; Tessa Reinders; L Marije Hofstra; Stefan Nierkens; Steven F T Thijsen; Michiel Heron; Robert-Jan Lebbink; Jeffrey M Beekman; Monique Nijhuis; Annemarie M J Wensing
Journal:  Open Forum Infect Dis       Date:  2021-11-06       Impact factor: 3.835

4.  Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs.

Authors:  Tafadzwa Dzinamarira; Nigel Tungwarara; Itai Chitungo; Munashe Chimene; Patrick Gad Iradukunda; Moreblessing Mashora; Grant Murewanhema; Gallican Nshogoza Rwibasira; Godfrey Musuka
Journal:  Vaccines (Basel)       Date:  2022-02-07

5.  Engineering monoclonal antibodies for COVID-19 prophylaxis.

Authors:  Amin Izadpanah; Jay Rappaport
Journal:  Med (N Y)       Date:  2022-03-11

6.  High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study.

Authors:  Klaus Hirschbühl; Tina Schaller; Sebastian Dintner; Claudia Wylezich; Bruno Märkl; Rainer Claus; Eva Sipos; Lukas Rentschler; Andrea Maccagno; Bianca Grosser; Elisabeth Kling; Michael Neidig; Thomas Kröncke; Oliver Spring; Georg Braun; Hans Bösmüller; Maximilian Seidl; Irene Esposito; Jessica Pablik; Julia Hilsenbeck; Peter Boor; Martin Beer
Journal:  Mod Pathol       Date:  2022-04-01       Impact factor: 8.209

7.  Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.

Authors:  Ramachandran Thiruvengadam; Amit Awasthi; Guruprasad Medigeshi; Sankar Bhattacharya; Shailendra Mani; Sridhar Sivasubbu; Tripti Shrivastava; Sweety Samal; Deepika Rathna Murugesan; Bapu Koundinya Desiraju; Pallavi Kshetrapal; Rajesh Pandey; Vinod Scaria; Praveen Kumar Malik; Juhi Taneja; Akshay Binayke; Tarini Vohra; Aymaan Zaheer; Deepak Rathore; Naseem Ahmad Khan; Heena Shaman; Shubbir Ahmed; Rajesh Kumar; Suprit Deshpande; Chandru Subramani; Nitya Wadhwa; Nimesh Gupta; Anil K Pandey; Jayanta Bhattacharya; Anurag Agrawal; Sudhanshu Vrati; Shinjini Bhatnagar; Pramod Kumar Garg
Journal:  Lancet Infect Dis       Date:  2021-11-25       Impact factor: 71.421

Review 8.  SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review.

Authors:  Caterina Ledda; Claudio Costantino; Giuseppe Motta; Rosario Cunsolo; Patrizia Stracquadanio; Giuseppe Liberti; Helena C Maltezou; Venerando Rapisarda
Journal:  Trop Med Infect Dis       Date:  2022-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.